These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 395437)

  • 1. [A case of Louis-Bar syndrome. Diagnostic problems and therapeutic prospects].
    Colonna F; Bonassi E; Beatrice M; Rinone R; Tovo PA
    Minerva Pediatr; 1979 Sep; 31(17):1267-71. PubMed ID: 395437
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ataxia telangiectasia or the Louis-Bar syndrome. Case reports].
    Vallarino G; Rainero L; Fregonese B; Merlini M; Zappa GP
    Minerva Pediatr; 1976 Mar; 28(7):407-11. PubMed ID: 1004438
    [No Abstract]   [Full Text] [Related]  

  • 3. Thymosin treatment of children with primary immunodeficiency disease.
    Wara DW; Ammann AJ
    Transplant Proc; 1978 Mar; 10(1):203-9. PubMed ID: 305674
    [No Abstract]   [Full Text] [Related]  

  • 4. Thymopoietin pentapeptide treatment of primary immunodeficiencies.
    Aiuti F; Businco L; Fiorilli M; Galli E; Quinti I; Rossi P; Seminara R; Goldstein G
    Lancet; 1983 Mar; 1(8324):551-4. PubMed ID: 6131256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of the immunological deficiency in ataxia-telangiectasia: absence of a clinical-pathological correlation.
    Roifman CM; Gelfand EW
    Kroc Found Ser; 1985; 19():273-85. PubMed ID: 3877786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of synthetic thymic hormone (TP5) in children with T-cell immunodeficiencies.
    Levinsky RJ; Davies EG; Goldstein G
    Birth Defects Orig Artic Ser; 1983; 19(3):273-6. PubMed ID: 6360239
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapy with thymopoietin pentapeptide (TP-5) in 26 patients with primary immunodeficiencies.
    Aiuti F; Businco L; Fiorilli M; Galli E; Quinti I; Le Moli S; Seminara R; Goldstein G
    Birth Defects Orig Artic Ser; 1983; 19(3):267-72. PubMed ID: 6360238
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinico-immunologic indices in patients with the Louis-Bar syndrome following transplantation of the thymus and sternum].
    Lopukhin IuM; Morozov IuI; Kalinina LV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(10):1484-91. PubMed ID: 4590542
    [No Abstract]   [Full Text] [Related]  

  • 9. Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency.
    Fiorilli M; Sirianni MC; Pandolfi F; Quinti I; Tosti U; Aiuti F; Goldstein G
    Clin Exp Immunol; 1981 Aug; 45(2):344-51. PubMed ID: 7032772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to thymopoietin pentapeptide in patient with DiGeorge syndrome.
    Aiuti F; Businco L; Rossi P; Quinti I
    Lancet; 1980 Jan; 1(8159):91. PubMed ID: 6101433
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantified deficiency of lymphocyte response to phytohaemagglutinin in immune deficiency diseases.
    Hosking CS; Fitzgerald MG; Simons MJ
    Clin Exp Immunol; 1971 Oct; 9(4):467-76. PubMed ID: 5123224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of thymic humoral factor on cellular immune factors of normal children and of pediatric patients with ataxia telangiectasia and Down's syndrome.
    Handzel ZT; Dolfin Z; Levin S; Altman Y; Hahn T; Trainin N; Gadot N
    Pediatr Res; 1979 Jul; 13(7):803-6. PubMed ID: 158166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The thymus in immunodeficiency diseases: new therapeutic approaches.
    Bach JF
    Birth Defects Orig Artic Ser; 1983; 19(3):245-53. PubMed ID: 6360235
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thymopentin and immune response in patients with cancer].
    Petronella P; Ferrone R; Freda F; Valeriani G
    Minerva Chir; 1989 Sep; 44(18):2017-20. PubMed ID: 2694011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ataxia-telangiectasia. (Clinical and immunological aspects).
    Boder E; Sedgwick RP
    Psychiatr Neurol Med Psychol Beih; 1970; 13-14():8-16. PubMed ID: 5006295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymopentin (TP-5) in the treatment of the postburn and postoperative immunodeficiency syndrome.
    Hamilton G; Zöch G; Rath T; Meissl G
    Prog Clin Biol Res; 1989; 308():995-9. PubMed ID: 2528748
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ataxia telangiectasia (Louis-Bar syndrome)].
    Gschnait F; Grabner G; Brenner W; Tappeiner J
    Hautarzt; 1979 Oct; 30(10):527-31. PubMed ID: 521274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological studies in ataxia-telangiectasia.
    Kiran O; Yalaz K; Taysi K; Say B
    Clin Genet; 1974 Jan; 5(1):40-5. PubMed ID: 4599963
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical-immunological study and transplantation of the thymus in the Louis-Bar syndrome].
    Lopukhin IuM; Badalian LO; Morozov IuI; Kalinina LV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(10):1466-70. PubMed ID: 5139407
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ataxia with telangiectasia--the Louis-Bar syndrome].
    Machula F; Schwartzová K; Amblerová V; Losan F
    Cesk Neurol Neurochir; 1981 Sep; 44(5):320-7. PubMed ID: 7307153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.